Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma
- 31 May 2002
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 96 (5) , 322-329
- https://doi.org/10.1053/rmed.2002.1282
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Comparison between formoterol 12 μ g b.i.d. and on-demand salbutamol in moderate persistent asthmaRespiratory Medicine, 2001
- ZafirlukastDrugs, 2001
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- A Comparison of Low-Dose Inhaled Budesonide plus Theophylline and High-Dose Inhaled Budesonide for Moderate AsthmaNew England Journal of Medicine, 1997
- Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter studyClinical Therapeutics, 1997
- Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functionsBritish Journal of Pharmacology, 1995
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in AsthmaNew England Journal of Medicine, 1992
- New aspects of the therapeutic potential of theophylline in asthmaJournal of Allergy and Clinical Immunology, 1989
- The effect of theophylline and enprofylline on allergen-induced bronchoconstrictionJournal of Allergy and Clinical Immunology, 1985